Involvement of apoptotic protease cascade for tissue destruction in Sjögren's syndrome

Archivum Immunologiae et Therapiae Experimentalis

Volumn 48, Issue 5, 2000, Pages 399-403

  Hayashi, Yoshio ^a   Yayagi, Kumiko ^a   Haneji, Norio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Apoptosis; Autoantigen; Protease; Sj gren's syndrome

Indexed keywords

ACTIN BINDING PROTEIN; AUTOANTIGEN; CARRIER PROTEIN; FAS ANTIGEN; FAS LIGAND; FASL PROTEIN, MOUSE; FASLG PROTEIN, HUMAN; FODRIN; MEMBRANE PROTEIN; PROTEINASE;

ANIMAL; APOPTOSIS; HUMAN; METABOLISM; MOUSE; MOUSE MUTANT; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; AUTOANTIGENS; CARRIER PROTEINS; ENDOPEPTIDASES; FAS LIGAND PROTEIN; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, MUTANT STRAINS; MICROFILAMENT PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; SJOGREN'S SYNDROME;

EID: 0034571292     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. BIEGANOWSKA K. D., AUSUBEL L. J., MODABBER Y., SLOVIK E., MESSERSMITH W. and HAFLER D. A. (1997): Direct ex vivo analysis of activated, Fas-sensitive autoreactive T cells in human autoimmune disease. J. Exp. Med., 185, 1585-1594.
2. BLOCH K. J., BUCHANAN W. W., WOHL M. J. and BUNIM J. (1965): Sjögen's syndrome. A clinical, pathological and serological study of sixty-two cases. Medicine, 44, 187-231.
3. BRUNNER T., MOGLL R. J., LA FACE D., YOO N. J., MAHBOUBL A., ECHEVERRI F., MARTIN S. J., FORCE W. R., LYNCH D. H., WARE C. F. and GREEN D. R. (1995): Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T cell hybridomas. Nature, 373, 441-444.
4. CASIANO C. A. (1996): Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J. Exp. Med., 184, 765-770.
5. CASIANO C. A., MARTIN S. J., GREEN D. R. and TAN E. T. (1996): Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1 )-mediated T cell apoptosis. J. Exp. Med., 184, 765-770.
6. CHAN E. K., HAMEL J. C., BUYON J. P. and TAN E. T. (1991): Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J. Clin. Invest., 87, 68-76.
7. CHERVONSKY A. V., WANG Y., WONG F. S., VISINTIN I., FLAVELL R. A., JANEWAY C. A. JR. and MATIS L. A. (1997): The role of Fas in autoimmune diabetes. Cell, 89, 17-24.
8. ENARI M., TALANIAN R. V., WONG W. W. and NAGATA S. (1996): Sequential activation of ICE-loke and CPP32-like proteases during Fas-mediated apoptosis. Nature, 380, 723-726.
9. FEINSTEIN E., KIMCHI A., WALLACH D., BOLDIN M. and VARFOLOMEEV E. (1995): The death domain: a module shared by proteins with diverse cellular function. Trends Biochem. Sci., 20, 342-344.
10. FELDMANN M., BENNAN F. M. and MAINI R. N. (1996): Rheumatoid arthritis. Cell, 85, 307-310.
11. Fox R. I. and SAITO I. (1995): Sjögren's syndrome. In ROBERT R. (ed.): Clinical immunology-principles and practice. Chapter 75. Mosby, 1145-1153.
12. GIANANI R. and SATVENTNICK N. (1989): Virus, cytokine, antigens, and autoimmunity. Proc. Natl. Acad. Sci. USA, 93, 2252-2259.
13. GIORDANO C., STASSI G., DE MARIA R., TODARO M., RICHIUSA P., PAPOFF G., RUBERTI G., BAGNASCO M., TESTI R. and GALLUZZO A. (1997): Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science, 275, 960-963.
14. HANEJI N., HAMONO H., YANAGI K. and HAYASHI Y. (1994): A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice. J. Immunol., 153, 2769-2777.
15. HANEJI N., NAKAMURA T., TAKIO K., YANAGI K., HIGASHIYAMA H., SAITO I., NOJI S., SUGINO H. and HAYASHI Y. (1997): Identification of α-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science, 276, 604-607.
16. HAYASHI Y., KOJIMA A., HATA M. and HIROKAWA K. (1988): A new mutationinvolving the sublingual gland in NFS/N mice. Am. J. Pathol., 132, 187-191.
17. HOLTZMAN D. M. and DESHMUKH M. (1997): Caspases: A treatment target for neurodegenerative disease? Nat. Med., 3, 954-955.
18. HUANG S., JIANG Y., LI Z., NISHIDA E., MATHIAS P., LIN S., ULEVITCH R. J., NEMEROW G. R. and HAN J. (1997): Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 familiy proteases and MAP kinase 6b. Immunity, 6, 739-749.
19. JU S.-T., PANKA D. J., CUI H., ETTINGER R., EL-KHATIB M., SHERR D. H., STANGER B. Z. and MARSHAK-ROTHSTEIN A. (1995): Fas(CD95) /FasL interactions required for programmed cell death after T-cell activation. Nature, 373, 444-448.
20. KOTHAKOTA S., AZUMA T., REINHARD C., KLIPPEL A., TANG J., CHU K., MCGARRY T. J., KIRSCHNER M. W., KOTHS K., KWIATKOWSKI D. J. and WILLIAMS L. T. (1997): Caspase-3-generated fragment of Gelsolin: Effector of morphological change in apoptosis. Science, 278, 294-298.
21. KRUIZE A. A., SMEENK R. J. T. and KATER L. (1995): Diagnostic criteria and immunopathogenesis of Sjögren's syndrome: implications for therapy. Immunol. Today, 16, 557-559.
22. MARTIN S. D., O'BRIEN G. A., NISHIOKA W. K., MCGAHON A. J., MAHBOUBI A., SAIDO T. C. and GREEN D. R. (1995): Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J. Biol. Chem., 270, 6425-6428.
23. MENAD H.-A. and EL-AMINE M. (1996): The calpain-calpastatin system in rheumatoid arthritis. Immunol. Today, 17, 545-547.
24. MIMORI T., SUGANUMA K., TANAMI Y., NOJIMA T., MATSUMURA M., FUJII T., YOSHIZAWA T., SUZUKI K. and AKIZUKI M. (1995): Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases. Proc. Natl. Acad. Sci. USA, 92, 7267-7271.
25. NAGATA S. and GOLDSTEIN P. (1995): The Fas death factor. Science, 267, 1449-1456.
26. NISHIO A., KATAKAI T., OSHIMA C., KASAKURA S., SAKAI M., YONEHARA S., SUDA T., NAGATA S. and MASUDA T. (1996): A possible involvement of Fas-Fas ligand signaling in the pathogenesis of murine autoimmune gastritis. Gastroenterology, 111, 956-967.
27. PATEL T., GORES G. J. and KAUFMANN S. H. (1996): The role of proteases during apoptosis. FASEB J., 10, 587-597.
28. RIEUX-LAUCAT F. (1995): Mutation in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science, 268, 1347-1349.
29. RUDEL T. and BOKOCH G. M. (1997): Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science, 276, 1571-1574.
30. SAITO I., HARUTA K., SHIMUTA M., INOUE H., SAKURAI H., YAMADA K., ISHIMARU N., HIGASHIYAMA H., SUMIDA T., ISHIDA H., SUDA T., NODA T., HAYASHI Y. and TSHUBOTA K. (1999): Fas ligand-mediated excrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10. J. Immunol., 162, 2488-2494.
31. SHIRASUNA K., SATO M. and MIYAZAKI T. (1981): A neoplastic epithelial duct cell line established from an irradiated human salivary gland. Cancer, 48, 745-752.
32. SUMIDA T., YONAHA F., MAEDA T., TANABE E., KOIKE T., TOMIOKA H. and YOSHIDA S. (1992): T cell receptor repertoire of infiltrating T cells in lips of Sjögren's syndrome patients. J. Clin. Ivest., 89, 681-685.
33. THOMPSON C. B. (1995): Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-1462.
34. UTZ P. J., HOTTELET M., SCHUR P. H. and ANDERSON P. (1997): Proteins phospholylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J. Exp. Med., 185, 843-854.